A Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer

Clinical trial NCT07130916 · RECRUITING

Trial details

NCT number: NCT07130916
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2024-12-05
Primary completion: 2025-08-09
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.